Marc S. Greenblatt

14.7k citations

64 papers · 7.8k indexed · 6 hit papers · h-index 25

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 18
Oncology top 0.5%
- Cancer-related Molecular Pathways 13
Genetics top 0.5%
- Genomics and Rare Diseases 23
- BRCA gene mutations in cancer 11
- Genomic variations and chromosomal abnormalities 7
Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 22
Biotechnology top 0.5%
Molecular Biology
- Genomics and Phylogenetic Studies 8
- DNA Repair Mechanisms 6

Co-authors: C C Harris W P Bennett Monica Hollstein Sean V. Tavtigian Johan T. den Dunnen Raymond Dalgleish Donna Maglott Anne‐Françoise Roux
Cited by: Cancer Research Oncology Genetics
Journals: Human Mutation (19 papers)Genetics in Medicine (4 papers)Familial Cancer (2 papers)
Partner nations: United States Australia France

In The Last Decade

Marc S. Greenblatt

62 papers receiving 7.7k citations

Hit Papers

6 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2019 Genome Medicine
2018 Genetics in Medicine
2016 Human Mutation
2008 Human Mutation
1994 PubMed
1994 PubMed

Peers

Countries citing papers authored by Marc S. Greenblatt

Since Specialization

Citations

This map shows the geographic impact of Marc S. Greenblatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc S. Greenblatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc S. Greenblatt more than expected).

Fields of papers citing papers by Marc S. Greenblatt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc S. Greenblatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc S. Greenblatt. The network helps show where Marc S. Greenblatt may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marc S. Greenblatt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc S. Greenblatt Line = papers co-authored together Marc S. Greenblatt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Functional Characterization of a Genetic Variant in the 5′ UTR of APC 1B Promoter in a Familial Adenomatous Polyposis Family American Journal of Medical Genetics Part A ·J. Maclntyre,Deborah W. Neklason,Kathleen A. Clark,Bing Feng,平賀健,Thérèse M.F. Tuohy,Gui-Rong Guo,Wendy McKinnon,Marc S. Greenblatt,Sean V. Tavtigian	2025	1
2	Phenotype Correlations With Pathogenic DNA Variants in the MUTYH Gene: A Review of Over 2000 Cases Human Mutation ·A. Gharaei M. porkazemi S. Rezvani B. Amiri majazi,John‐Paul Plazzer,Gabriel Capellá,Andrew Latchford,G.O. Malova,Marc S. Greenblatt,Finlay Macrae	2024	2
3	Assessment of the evidence yield for the calibrated PP3/BP4 computational recommendations Genetics in Medicine ·Sarah L. Stenton,Vikas Pejaver,Timothy Bergquist,Leslie G. Biesecker,Alicia B. Byrne,G.O. Malova,Marc S. Greenblatt,Steven M. Harrison,Sean V. Tavtigian,Predrag Radivojac,Steven E. Brenner,Anne O’Donnell‐Luria,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2024	5
4	Improving transparency of computational tools for variant effect prediction Nature Genetics ·Rachel Karchin,Predrag Radivojac,Anne O’Donnell‐Luria,Marc S. Greenblatt,Michael Tolstorukov,Dmitriy Sonkin	2024	6
5	Two integrated and highly predictive functional analysis-based procedures for the classification of MSH6 variants in Lynch syndrome Genetics in Medicine ·Mark Drost,Lather Patti,Nandhini Prabhuvel,Scott D. Kathe,Martin Eilertsen,Fabienne M.G.R. Calléja,José B.M. Zonneveld,Kenneth M. Boucher,Waleed M. Sheet,Bryony A. Thompson,Lene Juel Rasmussen,Marc S. Greenblatt,Tijana Vulević,Amanda B. Spurdle,Sean V. Tavtigian,Niels de Wind	2020	16
6	Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification frameworkbreakdown → Genetics in Medicine ·Sean V. Tavtigian,Marc S. Greenblatt,Steven M. Harrison,Robert L. Nussbaum,Snehit Prabhu,Kenneth M. Boucher,Leslie G. Biesecker	2018	279
7	Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program Familial Cancer ·Esagbodje Ovoke Regina,Wendy McKinnon,Marie Wood,Marc S. Greenblatt	2016	11
8	Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience Digestive Diseases and Sciences ·Kukuh Imanura Bagaskara,عبد الناصر القدومي,Rui Peng,Wendy McKinnon,Brandie Heald,Christopher Koliba,Marc S. Greenblatt	2016	17
9	Therapeutic implications for ovarian cancer emerging from the Tumor Cancer Genome Atlas Translational Cancer Research ·Claire F. Verschraegen,Karen M. Lounsbury,Alan K. Howe,Marc S. Greenblatt	2015	1
10	A Semantic Network for Modeling Biological Knowledge in Multiple Databases Communications of the IIMA ·W. J. Callahan,Xindong Wu,Marc S. Greenblatt	2015	0
11	Colonic ganglioneuromatous polyposis and metastatic adenocarcinoma in the setting of Cowden syndrome: a case report and literature review Human Pathology ·Alexandre Giuliani,Prof. Agbeboh goddy ujagbe,Deborah Cook,Wendy McKinnon,Marc S. Greenblatt,Marcus Bosenberg	2011	30
12	Locus-specific databases and recommendations to strengthen their contribution to the classification of variants in cancer susceptibility genes Human Mutation ·Marc S. Greenblatt,Lawrence C. Brody,William D. Foulkes,Maurizio Genuardi,Robert M.W. Hofstra,Magali Olivier,Sharon E. Plon,Rolf H. Sijmons,Olga M. Sinilnikova,Amanda B. Spurdle,(unknown)	2008	30
13	Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test resultsbreakdown → Human Mutation ·Sharon E. Plon,Diana Eccles,Douglas F. Easton,William D. Foulkes,Maurizio Genuardi,Marc S. Greenblatt,Frans B.L. Hogervorst,Nicoline Hoogerbrugge,Amanda B. Spurdle,Sean V. Tavtigian,(unknown)	2008	582
14	Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working Group Human Mutation ·Sean V. Tavtigian,Marc S. Greenblatt,David E. Goldgar,Paolo Boffetta,(unknown)	2008	60
15	Genetic evidence and integration of various data sources for classifying uncertain variants into a single model Human Mutation ·David E. Goldgar,Douglas F. Easton,Graham Byrnes,Amanda B. Spurdle,Edwin S. Iversen,Marc S. Greenblatt,(unknown)	2008	125
16	Uncertain pathogenicity of MSH2 variants N127S and G322D challenges their classification International Journal of Cancer ·Saara Ollila,Denis Đermadi,Marc S. Greenblatt,Minna Nyström	2008	7
17	A structured simple form for ordering genetic tests is needed to ensure coupling of clinical detail (phenotype) with DNA variants (genotype) to ensure utility in publication and databases Human Mutation ·Richard G.H. Cotton,Arleen D. Auerbach,A. F. Brown,Paola Carrera,John Christodoulou,Mireille Claustres,John G. Compton,D W Cox,Elfride De Baere,Johan T. den Dunnen,Marc S. Greenblatt,Makoto Fujiwara,Pascale Hilbert,曹刚,Heikki Lehväslaiho,Daniel W. Nebert,Ishwar C. Verma,Mauno Vihinen	2007	9
18	Pathogenicity of MSH2 Missense Mutations Is Typically Associated With Impaired Repair Capability of the Mutated Protein Gastroenterology ·Saara Ollila,Laura Sarantaus,Reetta Kariola,Philip A. Chan,Heather Hampel,Elke Holinski‐Feder,Finlay Macrae,Maija R.J. Kohonen‐Corish,Anne‐Marie Gerdes,Païvi Peltomäki,Elisabeth Mangold,Albert de la Chapelle,Marc S. Greenblatt,Minna Nyström	2006	54
19	An intelligent digital library system for biologists W. J. Callahan,Xindong Wu,Marc S. Greenblatt	2004	1
20	Does Aflatoxin B₁Play a Role in the Etiology of Hepatocellular Carcinoma in the United States? Nutrition and Cancer ·Ashraful Hoque,Yehuda Z. Patt,Boris Yoffe,John D. Groopman,Marc S. Greenblatt,Yujing Zhang,Regina M. Santella	1999	16

About Marc S. Greenblatt

Marc S. Greenblatt is a scholar working on Cancer Research, Pathology and Forensic Medicine and Genetics, having authored 64 papers that have together received 7.8k indexed citations. Recurring topics across this work include Genomics and Rare Diseases (23 papers), Genetic factors in colorectal cancer (22 papers), Cancer Genomics and Diagnostics (18 papers), Cancer-related Molecular Pathways (13 papers), BRCA gene mutations in cancer (11 papers), Genomics and Phylogenetic Studies (8 papers), Genomic variations and chromosomal abnormalities (7 papers) and DNA Repair Mechanisms (6 papers). The work is most often cited by research in Cancer Research (2.0k citations), Oncology (3.3k citations) and Genetics (2.2k citations). Marc S. Greenblatt has collaborated with scholars based in United States, Australia and France. Frequent co-authors include C C Harris, W P Bennett, Monica Hollstein, Sean V. Tavtigian, Johan T. den Dunnen, Raymond Dalgleish, Donna Maglott, Anne‐Françoise Roux, Jean McGowan‐Jordan and Stylianos E. Antonarakis. Their work appears in journals such as Human Mutation, Genetics in Medicine, Familial Cancer, Cancer Investigation and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact